(Salon) Three of the lawmakers who will lead the House next year as Congress focuses on skyrocketing drug costs are among the biggest recipients of campaign contributions from the pharmaceutical industry a new KHN analysis shows. On Wednesday House Democrats selected Rep. Steny Hoyer of Maryland to serve as the next majority leader and Rep. James Clyburn of South Carolina as majority whip making them the No. 2 and No. 3 most powerful Democrats as their party regains control of the House in January. Both lawmakers have received more than $1 million from pharmaceutical company political action committees in the past decade. Just four members of Congress hold that distinction including Rep. Kevin McCarthy of California whom Republicans chose as the next House minority leader earlier this month. Read More